| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/17/1999 | EP0896585A1 Humanized anti-cd40 monoclonal antibodies and fragments capable of blocking b cell activation |
| 02/17/1999 | EP0896584A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS |
| 02/17/1999 | EP0896583A1 Novel osp-c derived peptide fragments |
| 02/17/1999 | EP0896582A1 Non-dendritic backbone peptide carrier |
| 02/17/1999 | CN1208438A Transport proteins and their uses |
| 02/17/1999 | CN1208436A Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 02/17/1999 | CN1208420A Antisecretory factor peptides regulating pathological permeability changes |
| 02/17/1999 | CN1208078A Genes encoding branched-chain alpha-ketoacid dehydrogense complex from streptomyces Avermitilis |
| 02/17/1999 | CN1207946A Thioether conjugates |
| 02/16/1999 | US5872242 Antisense oligonucleotide inhibition of ras |
| 02/16/1999 | US5872237 Isolated nucleic acid sequences of dna or cdna for gene expression and dna sequences |
| 02/16/1999 | US5872234 Antitumor |
| 02/16/1999 | US5872233 Mycoplasma arthritidis T-cell mitogen |
| 02/16/1999 | US5872231 Nucleic acids encoding merosin |
| 02/16/1999 | US5872230 Regulation of transport of cholesterol into the mitochondria of a cell for the synthesis of androgens, estrogens, glucocorticoids, mineralocorticoids, and progestagens. the invention also relates to methods for detecting and treating |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872225 Method for characterizing the nucleotide sequence of L1CAM and the nucleotide sequence characterized thereby |
| 02/16/1999 | US5872221 Capable of binding epitopes of pthrp and a kit for the detection of pthrp or fragments thereof comprising one or more antibody reagents capable of binding to epitopes of pthrp |
| 02/16/1999 | US5872220 Antibodies to insulin-like growth factor binding protein IGFBP-6 |
| 02/16/1999 | US5872219 Antibodies drawn to the eps15 substrate for epidermal growth factor receptor kinase |
| 02/16/1999 | US5872218 Monoclonal antibodies |
| 02/16/1999 | US5872217 Antibodies which specifically bind a cancer related antigen |
| 02/16/1999 | US5872214 NF2 isoforms |
| 02/16/1999 | US5872213 Purified protein, designated ini-1, capable of interacting with the hiv-1 integrase |
| 02/16/1999 | US5872212 Pesticidal proteins and strains |
| 02/16/1999 | US5872210 Used in the treatment of virally infected cells, in the preparation of vaccine formulations, in the generation of clinically relevant antibodies and anti-idiotypic antibodies and in the generation of a screening assay or kit that can be |
| 02/16/1999 | US5872209 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of `aggrecanase` in cell culture systems |
| 02/16/1999 | US5872207 N-terminal-marked peptides immobilized on glass beads and method of preparation and method of use thereof |
| 02/16/1999 | US5872206 Polypeptides with amino acid sequences for screening |
| 02/16/1999 | US5872102 Method for isolation of bovine low-molecular weight CR-binding substance and method of use of the same |
| 02/16/1999 | US5872100 Peptides containing D-2-Alkyl-Tryptophan |
| 02/16/1999 | US5872099 Administering high molecular weight fraction having higher platelet aggregation activity; treatment of hemophilia a and other blood disorders |
| 02/16/1999 | US5872098 Nematode-extracted anticoagulant protein |
| 02/16/1999 | US5872097 Oligopeptides with affinity to opioid receptors |
| 02/16/1999 | US5872095 IL-1 receptor antagonists medicaments |
| 02/16/1999 | US5872094 Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface |
| 02/16/1999 | US5872012 Protamine-reactive IGM antibodies |
| 02/16/1999 | US5872011 Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof |
| 02/16/1999 | US5872005 Packaging cell lines for adeno-associated viral vectors |
| 02/16/1999 | US5872001 Lanthionine antibiotic compositions and methods |
| 02/16/1999 | US5871998 Gene expression in transformed eukaryotic host cell; genetic engineering |
| 02/16/1999 | US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871989 Phenylalanyl tRNA synthetase alpha subunit polynucleotides from streptococcus pneumoniae |
| 02/16/1999 | US5871984 Compounds and methods for site directed mutations in eukaryotic cells |
| 02/16/1999 | US5871982 Hybrid vectors and genes |
| 02/16/1999 | US5871974 Recombinant expression of heteromeric receptors on the surface of filamentous bacteriophage |
| 02/16/1999 | US5871973 Cell division regulators |
| 02/16/1999 | US5871971 Polynucleotide sequences and expression vectors or cells |
| 02/16/1999 | US5871970 Calcium-binding protein |
| 02/16/1999 | US5871969 Treating spinal cord injuries and malaria; antitumor and wound healing agents; diagnosing cancer; genetic engineering |
| 02/16/1999 | US5871968 P21WAF1 derivatives and diagnostic methods |
| 02/16/1999 | US5871967 Cloning of a novel G-Protein coupled 7TM receptor |
| 02/16/1999 | US5871965 Guanylate binding proteins |
| 02/16/1999 | US5871964 Human C-type lectin |
| 02/16/1999 | US5871963 Nucleotide sequences |
| 02/16/1999 | US5871962 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods |
| 02/16/1999 | US5871961 Nucleic acids encoding CR2 polypeptides, vector and transformed cell thereof, and expression thereof |
| 02/16/1999 | US5871960 Nucleic acids encoding CR5 polypeptide, vector and transformed cell thereof, and expression thereof |
| 02/16/1999 | US5871959 Method of producing hepatocycte growth factor/scatter factor and related cell lines |
| 02/16/1999 | US5871958 Mutant rev genes encoding transdominant repressors of HIV replication |
| 02/16/1999 | US5871957 Stable DNA constructs |
| 02/16/1999 | US5871956 Recombinant methods for production of serine inhibitors and DNA sequences useful for same |
| 02/16/1999 | US5871955 Field application vectors |
| 02/16/1999 | US5871945 Modulators of anchoring protein function |
| 02/16/1999 | US5871943 Immunoassay comprising a truncated pneumococcal surface protein A (PspA) |
| 02/16/1999 | US5871940 Assays for modulators of drosophila cation channel function |
| 02/16/1999 | US5871937 Complexing; binding gramnegative endotoxin secreted in gastrointestinal infections |
| 02/16/1999 | US5871934 Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins |
| 02/16/1999 | US5871933 Diagnosing, screening, and confirming infection with accuracy; vaccines |
| 02/16/1999 | US5871931 Methods for detecting mammalian tub protein and RNA |
| 02/16/1999 | US5871930 High affinity immunoglobulin E receptor-like protein |
| 02/16/1999 | US5871925 Determining whether two microsatellite markers are rearranged in tumor tissue; testing for familial colon cancer gene in humans; diagnosis, prognosis, prevention |
| 02/16/1999 | US5871920 Daz: a gene associated with azoospermia |
| 02/16/1999 | US5871919 Method of identifying agents that affect human NHE3 |
| 02/16/1999 | US5871916 Cancer diagnosis by analyzing gene expression of ecdn paucimolecular protein; receptor binding assays |
| 02/16/1999 | US5871913 Forms a complex with a human immunodeficiency virus envelope glycoprotein |
| 02/16/1999 | US5871911 Annealing target and pilot nucleic acids to form duplex; exposing to polymerase; genetic engineering |
| 02/16/1999 | US5871909 Human cellular retinoic acid binding protein I and II DNA and methods of use |
| 02/16/1999 | US5871904 Immunassay of non-A, non-B hepatitis virus-related antigens, monoclonal antibodies for use therein, and hybridomas producing the antibodies |
| 02/16/1999 | US5871903 HCV isolates |
| 02/16/1999 | US5871901 Assay for inhibitors of DP-1 and other DP proteins |
| 02/16/1999 | US5871753 A compound comprising two or more multimerized ligands each independently selected from the group consisting of fk506, fk520 and cyclosporin, or macrocyclic derivatives thereof. |
| 02/16/1999 | US5871750 Leukotoxin vaccine compositions and uses thereof |
| 02/16/1999 | US5871746 For immunizing against pathogenic agents such as viruses orparasites; one or more chains derived from fatty acids or modified steroid groups |
| 02/16/1999 | US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871744 Method for generating birnavirus from synthetic RNA transcripts |
| 02/16/1999 | US5871742 Dna codes for polypeptides with amino acid sequences |
| 02/16/1999 | US5871740 Genetic engineering with proteins, antiinflammatory agents and gene expression |
| 02/16/1999 | US5871739 Pharmaceutical composition |
| 02/16/1999 | US5871738 Nematode vaccine |
| 02/16/1999 | US5871737 Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein |
| 02/16/1999 | US5871734 Treatment for asthma with VLA-4 blocking agents |
| 02/16/1999 | US5871733 Viricides with intracellular adhesion molecule proteins for binding rhinovirus |
| 02/16/1999 | US5871732 Dna sequences and genetic engineering for aids |
| 02/16/1999 | US5871727 Targeted adenovirus vectors |
| 02/16/1999 | US5871724 Administering to the subject an amount of a transforming growth factor beta 3 effective to slow the growth of normal cells |
| 02/16/1999 | US5871712 Neurodegenerative condition, antiischemic agents and antibodies |
| 02/16/1999 | US5871711 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 02/16/1999 | CA2142297C Liquid detergents containing a peptide aldehyde |
| 02/16/1999 | CA2138020C Pharmaceutical composition containing botulinum b complex |